Everything listed here is Research Use Only (RUO). Not for human or animal consumption.
Metabolic & Weight Management · Washington, DC
Adipotide is documented by ReVia for metabolic-research laboratories in Washington, DC and the broader East Coast science community. This peptidomimetic compound is studied for targeted adipose tissue apoptosis and vascular-disruption mechanisms in fat-cell models, and each lot includes third-party COA verification. Supplied for laboratory and research use only to the capital region, from the District to Bethesda.
A pro-apoptotic peptidomimetic that targets the vascular supply of white adipose tissue. Primate studies have investigated selective ablation of adipose vasculature and its effects on adipose tissue metabolism.
Categorized as a vascular-targeting peptidomimetic, Adipotide draws attention from the capital region's science-forward laboratories examining how its dual-motif design engages adipose endothelial markers in vitro. With institutional research spanning Arlington, Alexandria, and Bethesda, Washington investigators characterize the compound's receptor binding and apoptotic signaling, reflecting the area's depth in preclinical molecular study conducted entirely for research use.
Adipotide (FTPP) is worked with by researchers throughout the Washington metro — including Arlington, Alexandria, Bethesda, Silver Spring — and across East Coast. The capital region's science-forward market. Every ReVia-branded lot carries its own certificate of analysis, and the compound is intended strictly for research use.
Where do researchers in Washington, DC obtain Adipotide?
Yes, Adipotide is supplied through i2b Health, ReVia's research partner to researchers in Washington, DC and surrounding areas including Arlington and Alexandria. All supply is labeled research use only.
Is Adipotide independently COA tested?
Each Adipotide lot is verified by third-party laboratory analysis, with a certificate of analysis documenting identity and purity. Reports are available to support the capital region's research standards.
What is Adipotide studied for?
Adipotide is investigated as a peptidomimetic for targeted adipose tissue apoptosis and vascular disruption within fat-cell research models. It is intended exclusively for in-vitro study, not for human or animal use.
For research use only. Not for human or veterinary use. The information on this page is provided for educational and research purposes and does not constitute medical advice.